Jam
-
New Study Forecasts 2025 is the Year AI Transforms Customer Experience
Verint’s “State of Customer Experience 2025” report reveals AI adoption is crucial for businesses. Key findings include consumer preference for AI-driven solutions and digital channels and demand for quick issue resolution. Speed of service now outweighs empathy. A negative experience can greatly impact brand loyalty. Excellent CX drives repeat purchases and recommendations.
-
Heineken Holding N.V.: Transactions Reported Under Current Share Buyback Program
Heineken Holding N.V. announced share buyback transactions for the week of June 9-13, 2025. In this first tranche of a €750 million program, 70,010 shares were repurchased at an average price of €69.01. As of June 13, 2025, a total of 1,133,263 shares have been repurchased for €77,340,867. Weekly updates are available on the company website.
-
Zeus North America Mining Corp. Reports Gold, Silver, and Antimony Assay Results from Selway Property, Idaho
Zeus North America Mining Corp. announced promising rock grab sample results from its Selway Property in Idaho. The property, located east of Kamiah, Idaho, targets an intrusive-related Au-Ag vein deposit. Historical samples yielded significant silver and gold. Zeus plans follow-up sampling and ground geophysical programs in 2025. Dean Besserer, President & CEO, a Qualified Person, reviewed and approved the informational release.
-
TotalEnergies Deepens U.S. Offshore Footprint: Expands Partnership with Chevron in 40 Exploration Blocks
TotalEnergies acquired a 25% stake in 40 offshore exploration leases from Chevron in the U.S., spanning ~1,000 sq km across Walker Ridge, Mississippi Canyon, and East Breaks areas. This expands TotalEnergies’ U.S. offshore presence, building on collaborations with Chevron in projects like Ballymore and Anchor. The move reinforces TotalEnergies’ commitment to low-emission projects and its integrated energy strategy, including significant investments in LNG and renewables in the U.S. since 2022.
-
e.l.f. Launches “color e.l.f.nalysis” with Curated Pinterest Boards
e.l.f. Cosmetics introduces “color e.l.f.nalysis,” a free digital tool offering personalized beauty advice. By analyzing a selfie, the tool determines a user’s color season and recommends curated Pinterest boards featuring shoppable e.l.f. products. Developed in partnership with Pinterest, the tool aims to democratize color analysis and make personalized beauty accessible.
-
Mariah Carey to be Next FF 91 2.0 Owner, Faraday Future Announces
Mariah Carey will soon own an FF 91 2.0 and showcases the vehicle and FFZERO1 concept car in her new music video, “Type Dangerous,” which also features MrBeast. This partnership aims to reinforce Faraday Future’s “Ultimate AI TechLuxury” branding. YT Jia, Faraday Future’s founder, welcomes Carey to the FF 91 2.0 owner family.
-
Innovent Completes First Dosing in Seventh Phase 3 Trial of Mazdutide in China (GLORY-OSA)
Innovent Biologics initiated a Phase 3 trial (GLORY-OSA) in China for mazdutide, a dual GCG and GLP-1 receptor agonist. The study will evaluate the drug’s efficacy and safety in Chinese patients with obesity and moderate-to-severe obstructive sleep apnea (OSA). Mazdutide has shown potential in weight loss and metabolic improvements, representing a potential treatment for a condition that affects millions in China, where current diagnosis rates are low. This marks the seventh Phase 3 study for the drug.
-
Bombardier Global 7500 Sets Speed Record on Montréal-Paris Flight
Bombardier’s Global 7500 sets a new speed record on a flight from Montreal to Paris, completing the journey in 5 hours and 30 minutes at over 1,000 km/hr. The aircraft showcases its superior performance and ability to connect global cities swiftly. The Global 7500 consistently achieves impressive real-world results, solidifying its place as a premier business jet, with the Global 8000 on the horizon.
-
Dupixent® (dupilumab) Outperforms Xolair® (omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Patients with Asthma: First-of-its-Kind Phase 4 Head-to-Head Respiratory Trial
The EVEREST Phase 4 trial presented at the 2025 EAACI conference demonstrated that Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and asthma. The study showed superior results for Dupixent across all endpoints for both conditions, including nasal polyp size reduction, improved smell, and enhanced lung function. This head-to-head comparison represents a significant milestone in respiratory disease treatment.
-
FranklinCovey Webinar: Leadership in Uncertain Times with Bestselling Authors
FranklinCovey is hosting a webinar on June 16, 2025, featuring Amy Edmondson, Stephen M. R. Covey, and Liz Wiseman. The discussion will delve into how leaders can thrive amidst constant disruption, addressing the leadership crisis, engagement recession, and adaptability dilemma. The event will explore strategies for navigating uncertainty and fostering successful, resilient organizations.